If a woman becomes infected with Plasmodium falciparum during pregnancy, her health and that of the fetus and newborn infant are at risk. In 1986, the WHO recommended that pregnant women use chloroquine chemoprophylaxis as a means of preventing the adverse effects of malaria. Today chloroquine resistance is widespread, and malariologists are attempting to produce a vaccine that will protect pregnant women. Unfortunately, little is known about why some women experience severe malaria during pregnancy and others do not, or why the incidence of spontaneous abortions, stillbirths, premature deliveries and low birthweight babies are increased by malaria infection. It is likely that changes within the placenta occur that contribute to retarded fetal development. In the studies described herein, we propose to test the hypotheses 1) that there is a relationship between high parasitemias in the placenta and increased risk of altered fetal development; 2) that high parasitemias occur in the placenta because it is a specialized immunologic environment where parasite-specific immune responses are suppressed; 3) alternatively, that women with unsuccessful pregnancies are infected with a more virulent strain of malaria than those with successful pregnancies; 4) that within the placenta parasites induce the synthesis of tumor necrosis factor (TNF) which alters antigenic expression of syncytiotrophoblasts resulting in reduced fetal retention; and 5) that the presence of parasites sequestered in the placenta can be detected in women who are blood-smear negative by detecting soluble malarial antigens in their serum or urine. Basic information from the proposed studies should help in the development of a vaccine that reduces fetal and infant mortality, as well as identify a method for accurately diagnosing malaria in pregnant women.

Project Start
1997-04-01
Project End
1998-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Chang, Sandra P; Kayatani, Alexander K K; Terrientes, Zilka I et al. (2010) Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4. Malar J 9:14
Thévenon, Audrey Davidson; Zhou, James A; Megnekou, Rosette et al. (2010) Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation. J Immunol 185:7115-22
Taylor, Diane Wallace; Zhou, Aniong; Marsillio, Lauren E et al. (2004) Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women. Infect Immun 72:1603-7
Johnson, Armead H; Leke, Rose G F; Mendell, Nancy R et al. (2004) Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1. Infect Immun 72:2762-71
Xi, Guoling; Leke, Rose G F; Thuita, Lucy W et al. (2003) Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies. Infect Immun 71:1242-6
Zhou, Ainong; Megnekou, Rosette; Leke, Robert et al. (2002) Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women. Am J Trop Med Hyg 67:566-70
Staalsoe, T; Megnekou, R; Fievet, N et al. (2001) Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 184:618-26
O'Neil-Dunne, I; Achur, R N; Agbor-Enoh, S T et al. (2001) Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun 69:7487-92
Johnson, A; Leke, R; Harun, L et al. (2000) Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect Immun 68:2231-6
Ellis, J M; Mack, S J; Leke, R F et al. (2000) Diversity is demonstrated in class I HLA-A and HLA-B alleles in Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-B*1403, *4016, *4703. Tissue Antigens 56:291-302

Showing the most recent 10 out of 11 publications